[overview]
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms.
stage
founded
region
fund
[details]
No related items found.
[featured articles]
.svg){kind=logo}
.png)
